Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact

Remdesivir and dexamethasone are the only drugs providing reductions in the lengths of hospital stays for COVID-19 patients. We assessed the impacts of remdesivir on hospital-bed resources and budgets affected by the COVID-19 outbreak. A stochastic agent-based model was combined with epidemiological...

Descripción completa

Detalles Bibliográficos
Autores principales: Béraud, Guillaume, Timsit, Jean-François, Leleu, Henri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754316/
https://www.ncbi.nlm.nih.gov/pubmed/35020746
http://dx.doi.org/10.1371/journal.pone.0262462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754316/
https://www.ncbi.nlm.nih.gov/pubmed/35020746
http://dx.doi.org/10.1371/journal.pone.0262462

Ejemplares similares